Can spiritual sessions ease the toll of leukemia treatment?
NCT ID NCT07405424
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looks at whether adding guided spiritual care sessions to standard hospital care is possible and helpful for adults newly diagnosed with acute leukemia. Seventy participants will be randomly assigned to receive either regular spiritual visits or usual care. The goal is to see if patients accept the sessions and if they report better spiritual well-being and quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- guided spiritual care sessions
- What this could lead to
- If it works, this could show that adding spiritual care to standard treatment improves emotional well-being and quality of life for leukemia patients.
- What could go wrong
- This is a small, early feasibility study (70 participants) and does not test survival or cure. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 70 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jun 2026
An estimate. Start dates often move.
- Expected to finish
-
Jun 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion criteria * Adults (18 years or older) * Diagnosis of Acute Leukemia (AML or ALL) undergoing inpatient initial therapy * Ability to read, understand, and speak the English language * Ability to understand and the willingness to sign a written informed consent document Exclusion criteria * Unable to comply with spiritual care intervention * Relapsed or refractory acute leukemia * Cognitive deficits that limit participation and survey questionnaire completion
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acute leukemia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
UChicago Medicine Comprehensive Cancer Center
RECRUITINGChicago, Illinois, 60637, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tweaking donor cells may shield older transplant patients from a dangerous complication
- Can a Nine-Week group program help blood cancer patients grow through trauma?
- Two-Drug combo aims to push CLL into deep remission
- Vaccine aims to train immune system against blood cancers
- Aloe vera mouthwash tested against chemotherapy mouth sores
- Can blood tests predict transplant complications?